Use of topical corticosteroids and topical calcineurin inhibitors for the treatment of atopic dermatitis in thin and sensitive skin areas

被引:43
|
作者
Draelos, Zoe D. [1 ]
机构
[1] Wake Forest Univ, Sch Med, Winston Salem, NC 27109 USA
关键词
atopic dermatitis; calcineurin inhibitors; corticosteroids; pimecrolimus; sensitive; skin; tacrolimus;
D O I
10.1185/030079908X280419
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background.-Atopic dermatitis (AD) is a common, chronic skin disorder characterized by itch and dry skin, which can develop into pruritic red plaques that ooze when scratched. AD flares often occur in anatomic areas where the skin is naturally thin (the face, neck, and intertriginous zones). Such regions, especially the face, are also areas of sensitive skin and need special consideration when being treated. Objective: This article will briefly review the concepts of thin and sensitive skin and discuss the treatment of AD in such areas. Methods: The MEDLINE database was searched for English-language articles published that contained the text terms atopic dermatitis, sensitive skin, treatment, topical corticosteroids, or topical calcineurin inhibitors. Articles that pertained to the safety and efficacy of various treatments were selected for further review. Results: Topical corticosteroids (TCSs) are effective for the treatment of AD in thin and sensitive skin areas, but their use is limited due to adverse events, such as skin thinning, and the potential for impairing the skin barrier. Topical calcineurin inhibitors (TCls) also provide effective AD treatment without impairing the skin barrier or inducing skin thinning. Although TCls may be associated with a higher incidence of applicationsite reactions such as pruritus and skin burning, these symptoms are typically transient and mild to moderate in nature. Limitations: This analysis focused primarily on relatively recent key trials evaluating the treatment of AD in sensitive skin; due to the limited number of controlled trials evaluating TCS agents, consensus statements and comprehensive review articles were used for most of the information pertaining to this therapeutic option. Conclusions: Although both TCSs and TCls have a place in a long-term, comprehensive treatment strategy for AD, TCls may have a particular use in thin and sensitive skin areas.
引用
收藏
页码:985 / 994
页数:10
相关论文
共 50 条
  • [31] Topical corticosteroids for atopic dermatitis
    Braschi, Emelie
    Young, Jennifer
    Allan, G. Michael
    CANADIAN FAMILY PHYSICIAN, 2024, 70 (09) : 558 - 558
  • [32] Evaluation of cancer risk related to atopic dermatitis and use of topical calcineurin inhibitors
    Tennis, P.
    Gelfand, J. M.
    Rothman, K. J.
    BRITISH JOURNAL OF DERMATOLOGY, 2011, 165 (03) : 465 - 473
  • [33] Skin cancer risk among adults with atopic dermatitis exposed to topical calcineurin inhibitors
    Feng, J.
    Tsai, A.
    Raimondo, D.
    Quesenberry, C. P.
    Asgari, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (05) : S55 - S55
  • [34] Safety of topical calcineurin inhibitors in atopic dermatitis: Evaluation of the evidence
    Spergel, Jonathan M.
    Leung, Donald Y. M.
    CURRENT ALLERGY AND ASTHMA REPORTS, 2006, 6 (04) : 270 - 274
  • [35] Safety of topical calcineurin inhibitors in atopic dermatitis: Evaluation of the evidence
    Jonathan M. Spergel
    Donald Y. M. Leung
    Current Allergy and Asthma Reports, 2006, 6
  • [36] Topical Corticosteroids for Treatment-Resistant Atopic Dermatitis
    Okwundu, Nwanneka
    Cardwell, Leah A.
    Cline, Abigail
    Unrue, Emily L.
    Richardson, Irma M.
    Feldman, Steven R.
    CUTIS, 2018, 102 (03): : 205 - +
  • [37] Topical calcineurin inhibitors vs. topical corticosteroids in the treatment of lichen planopilaris
    Ezemma, Ogechi
    Devjani, Shivali
    Ali, Shaheir
    Collins, Maya
    Kelley, Kristen
    Stratton, Emma
    Senna, Maryanne
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB98 - AB98
  • [38] The treatment of atopic eczema in adults with topical calcineurin inhibitors
    Meurer, M
    Wozel, G
    HAUTARZT, 2003, 54 (05): : 424 - 431
  • [39] Systematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitis
    Elaine C. Siegfried
    Jennifer C. Jaworski
    Jennifer D. Kaiser
    Adelaide A. Hebert
    BMC Pediatrics, 16
  • [40] Systematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitis
    Siegfried, Elaine C.
    Jaworski, Jennifer C.
    Kaiser, Jennifer D.
    Hebert, Adelaide A.
    BMC PEDIATRICS, 2016, 16